Laboratory medicine is facing an exciting era in the transforming Molecular Pathology landscape that aims to foster the delivery of high-impact innovation on the bases of complex informatics, for benefits to patient care, academic research and UK industry. With a vision of creating the next generation of leaders in Molecular Pathology, this programme will provide the state of the art training programme for Molecular Pathology, in order to facilitate the pathologists, clinical scientists, trainees, and to those in the related health professions, to acquire essential knowledge, skills and attributes in the current and future diagnosis that incorporates molecular knowledge.
Why this programme
● In August 2014, MRC published a review of the UK Molecular Pathology Landscape, in which the critical needs and challenges are pin downed in the delivery of improved diagnostics incorporating the molecular approaches.
● With a vision of creating the next generation of leaders, this programme provides state of the art training for Molecular Pathology
● We are one of the few centres where molecular pathology and diagnostic histopathology are amalgamated on one site, permitting the delivery of a clinically relevant molecular pathology course.
● The areas of main focus include diagnostic molecular pathology, clinical trials and translational research in molecular pathology, pathology bioinformatics and digital pathology. The core courses (PgCert) are designed to cover the intended learning outcomes within Royal College of Pathologists curriculum for Specialty Training in Histopathology 2015.
● The programme is led by the national leaders directly engaged in the various molecular pathology initiatives. Students are kept up-to-date with information and the current needs identified by the professional societies, research councils and charity organizations.
● You will be trained at the purpose-built Laboratory Medicine Building at the Queen Elizabeth University Hospital, which provides services to 52% of the Scottish population. This is one of the largest NHS department of pathology in Europe, accommodating about 50 consultant pathologists.
● The courses will be delivered by a range of professionals with expertise from geneticists, pathologists, clinical, lab scientists and academics, informaticians and clinicians provided across hospital practice and primary care. They are experts based in QEUH and those nationally and internationally recognized experts of molecular pathology.
The main aims of the MSc Molecular Pathology programme are to enable students:
• to fully provide a high quality service in molecular pathology diagnosis
• to participate in research in the area of molecular pathology
• to participate in the training of future generations of molecular pathologists
The "Blended Learning" programme offers the maximum flexibility for students who wish to study Molecular Pathology while on clinical duties and pathology training. "Moodle-Based Learning" sessions offer an advantage allowing clinicians to study within their own schedule. "In person review" sessions will enable active interactions with the course contributors and other students. Case-based and "hands-on" sessions facilitate the knowledge and skills acquired in clinical diagnosis as the programme proceeds, so it is easy to keep motivated throughout the course.
– 3 x compulsory, 20-credit courses; 1 per semester
• Fundamentals of Molecular Biology and Genetics for Histopathology (20 credits)
• Molecular Tests and Techniques for Histopathology (20 credits)
• Multidisciplinary Approaches to Molecular Pathology (20 credits)
The first three core components will provide the minimum requirement for students to apply molecular knowledge and skill in pathology diagnosis currently on-going and in the immediate future.
These courses will form the PgCert.
- Courses must be selected from the following options to obtain a total of 60 credits.
• Translational Medical Research Approaches (10 credits)
• Medical and Research Ethics (10 credits)
• Molecular Pathology (20 credits)
• Omics technologies for biomedical sciences: from genomics and metabolomics (20 credits)
• Frontiers in Cancer Science (20 credits)
• Disease Screening in Populations (10 credits)
• Governance and ethics in education research (10 credits)
In the advanced component, students will further their training of Molecular Pathology to acquire the knowledge needed to get involved in research, or development and improvement of diagnostics. There are options for learning of advanced technologies, wider disease areas, research methods, in-depth bioinformatics, and health professional education.
Successful completion of core and advanced courses will be awarded with the PgDip.
- 1 x 60-credit project-based course assessed by a dissertation of approximately 8,000 words followed by an oral presentation.
The Masters dissertation project gives students the opportunity to conduct research in an area of Molecular Pathology with supervisor(s) assigned to each project. For example, the opportunity to conduct an independent research project, audit or critical review of the literature in selected topics in the area of Molecular Pathology, current and future diagnosis, clinical and scientific research.
Successful completion of all core and advanced courses and the dissertation will lead to the award of the MSc.